2021Alruwaili A PhD.pdf (4.16 MB)
Download file

Understanding the Anti-inflammatory Effect of C-peptide in Kidney

Download (4.16 MB)
posted on 02.09.2021, 13:03 by Abdullah S. H. Alruwaili
Patients with diabetes are at high risk of developing long-term complications, including diabetic kidney disease. Recent data suggest that type 1 diabetes might be a dual hormone deficiency disease in which secretion of insulin and C-peptide is insufficient. Insulin supplementation is provided as part of treatment regimes, however, C-peptide depletion remains untreated. In this study, the potential beneficial effect of C-peptide replacement on renal cell signalling and biochemical markers of inflammation was investigated. Using cultured human renal cells (HEK-293A and TERT/1), incubation with 0.3 to 10nM C-peptide resulted in stimulatory effects on the key intracellular signalling pathway to MAP kinase (ERK1/2).
This effect was further investigated in presence of 2.5mM inorganic phosphate (Pi), a plasma Pi concentration that occurs in in rodents but not in healthy humans. Both Pi and C-peptide activated ERK1/2 in TERT/1 cells, and a positive interaction (synergism) was found between the effects of Pi and C-peptide. This response to Pi occurred without detectable change in the intracellular Pi concentration and was mimicked by non-metabolisable Pi analogues orthovanadate, phosphite and hypophosphite, consistent with a recent report of sensing of extracellular Pi by SLC20 transporter proteins (PiT1 and PiT2) in the plasma membrane which then signal to ERK1/2. C-peptide (at a physiologically relevant concentration of 3nM) also decreased mRNA expression of Pi transporters PiT2 and XPR1 and the activity of total Na+-linked Pi influx by 30% in TERT/1 cells, suggesting that C-peptide may contribute to regulation of renal Pi transport.
The proposed renoprotective effect of C-peptide was investigated in vivo. Streptozotocin-induced diabetes in rats resulted in upregulation of transforming growth factor-β and Type IV collagen. Administration of C-peptide prevented diabetes-induced overexpression of TGF-β and Col-IV mRNA, and TGF-β protein in kidney tissue. C-peptide administration also resulted in down-regulation of inflammatory marker proteins; monocyte chemo-attractant protein-1, inter-cellular adhesion molecule-1, vascular cell adhesion molecule-1, vascular endothelial growth factor-A, RANTES, tumour necrosis factor-α and interleukin-1β. Despite the older views that portrayed C-peptide as an inert molecule with no bioactivity, the data presented in this study, add to growing evidence supporting an active role for C-peptide in the diabetic milieu, and suggest that (at least in vitro) the response to C-peptide may be enhanced at the elevated extracellular Pi concentration.



Nigel Brunskill

Date of award


Author affiliation

School of Medicine

Awarding institution

University of Leicester

Qualification level


Qualification name




Usage metrics